Activin, TGF-β and Menin in Pituitary Tumorigenesis

被引:0
作者
Lebrun, Jean-Jacques [1 ]
机构
[1] McGill Univ, Royal Victoria Hosp, Dept Med, Hormones & Canc Res Unit, Montreal, PQ H3A 1A1, Canada
来源
SUPERMEN1: PITUITARY, PARATHYROID AND PANCREAS | 2009年 / 668卷
基金
加拿大健康研究院;
关键词
GROWTH-FACTOR-BETA; MULTIPLE ENDOCRINE NEOPLASIA; TUMOR-SUPPRESSOR GENE; CELL-GROWTH; EPITHELIAL-CELLS; SMAD PROTEINS; EXPRESSION; MUTATIONS; PROLACTIN; ADENOMAS;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Pituitary adenomas are common monoclonal neoplasms accounting for approximately one-fifth of primary intracranial tumors. Prolactin-secreting pituitary adenomas (prolactinomas) are the most common form of pituitary tumors in humans. They are associated with excessive release of the hormone prolactin and increased tumor growth, giving rise to severe endocrine disorders and serious clinical concerns for the patients. Recent studies indicated that the activin/TGF-beta family of growth factors plays a prominent role in regulating pituitary tumor growth and prolactin secretion from anterior pituitary lactotrope cells. Furthermore, these studies highlighted the tumor suppressor menin and the protein Smads as central regulators of these biological processes in the pituitary. Alterations in the activin/TGF-beta downstream signaling pathways are critical steps towards tumor formation and progression. This chapter will review the role and intracellular molecular mechanisms of action by which activin, TGF-beta, Smads and menin act in concert to prevent pituitary tumor cell growth and control hormonal synthesis by the anterior pituitary.
引用
收藏
页码:69 / 78
页数:10
相关论文
共 50 条
  • [21] The Love-Hate Relationship Between TGF-β Signaling and the Immune System During Development and Tumorigenesis
    Chen, Baode
    Mu, Chenglin
    Zhang, Zhiwei
    He, Xuelin
    Liu, Xia
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [22] TGF-β Signaling
    Tzavlaki, Kalliopi
    Moustakas, Aristidis
    BIOMOLECULES, 2020, 10 (03)
  • [23] Myeloid TGF-β signaling contributes to colitis-associated tumorigenesis in mice
    Li, Jingyi
    Liu, Yun
    Wang, Boshi
    Xu, Yingqian
    Ma, Aihui
    Zhang, Feng
    Ge, Chao
    Yang, Zhaojuan
    Li, Jinjun
    Liu, Yongzhong
    CARCINOGENESIS, 2013, 34 (09) : 2099 - 2108
  • [24] Role of TGF-β signaling in uterine carcinosarcoma
    Dwivedi, Shailendra Kumar Dhar
    McMeekin, Scott D.
    Slaughter, Katrina
    Bhattacharya, Resham
    ONCOTARGET, 2015, 6 (16) : 14646 - 14655
  • [25] Structural studies of the TGF-βs and their receptors - insights into evolution of the TGF-β superfamily
    Hinck, Andrew P.
    FEBS LETTERS, 2012, 586 (14) : 1860 - 1870
  • [26] TGFβ and activin A in the tumor microenvironment in colorectal cancer
    Zessner-Spitzenberg, Jasmin
    Thomas, Alexandra L.
    Krett, Nancy L.
    Jung, Barbara
    GENE REPORTS, 2019, 17
  • [27] Role of TGF-β in Melanoma
    Busse, A.
    Keilholz, U.
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2011, 12 (12) : 2165 - 2175
  • [28] Wound-induced TGF-β1 and TGF-β2 enhance airway epithelial repair via HB-EGF and TGF-α
    Ito, Jun
    Harada, Norihiro
    Nagashima, Osamu
    Makino, Fumihiko
    Usui, Yoshihiko
    Yagita, Hideo
    Okumura, Ko
    Dorscheid, Delbert R.
    Atsuta, Ryo
    Akiba, Hisaya
    Takahashi, Kazuhisa
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 412 (01) : 109 - 114
  • [29] Caveolin and TGF-β Entanglements
    Meyer, Christoph
    Liu, Yan
    Dooley, Steven
    JOURNAL OF CELLULAR PHYSIOLOGY, 2013, 228 (11) : 2097 - 2102
  • [30] Soluble CD109 binds TGF-β and antagonizes TGF-β signalling and responses
    Li, Carter
    Hancock, Mark A.
    Sehgal, Priyanka
    Zhou, Shufeng
    Reinhardt, Dieter P.
    Philip, Anie
    BIOCHEMICAL JOURNAL, 2016, 473 : 537 - 547